Loading data
DMACNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 24.61 m USD | 19.06 m USD | 13.11 m USD | 7.84 m USD | 8.77 m USD |
| Operating profit | -34.4 m USD | -26.68 m USD | -21.27 m USD | -14 m USD | -13.65 m USD |
| Profit before tax | -32.74 m USD | -24.41 m USD | -19.34 m USD | -13.65 m USD | -13.56 m USD |
| Income tax expense | 28 k USD | 30 k USD | 43 k USD | 28 k USD | 28 k USD |
| Net income (reported basis) | -32.77 bn USD | -24.44 bn USD | -19.38 bn USD | -13.68 m USD | -13.59 m USD |
| Basic earnings per share | -0.7 USD/share | -0.6 USD/share | -0.6 USD/share | -0.52 USD/share | -0.65 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.